vorasidenib
servier
['vorasidenib', 'indigo']
 plenary session i: indigo trial is practice changing.
vorasidenib improve pfs and ttni in patients with diffuse gliomas with idh1/2 mutations who were not in the need of immediate chemo or radiotherapy #asco23 
Prof. Ordinario Oncologia Università Politecnica delle Marche. Direttrice della Clinica Oncologica dell’Azienda Ospedaliero Universitaria delle Marche